NNNN

$21.50

Post-MarketAs of Mar 17, 8:00 PM UTC

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$21.50
Potential Downside
94.4%
Whystock Fair Value$1.21
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Instruments & Supplies

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$943.66M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
358.33
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
11.20%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
130.75

Recent News

Simply Wall St.
Jan 1, 2026

Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Most readers would already be aware that Anbio Biotechnology's (NASDAQ:NNNN) stock increased significantly by 18% over...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jul 13, 2025

Anbio Biotechnology (NASDAQ:NNNN) Has A ROE Of 14%

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Jul 11, 2025

Here Is What You Need To Know Before Investing In Anbio Biotechnology (NNNN)

Anbio Biotechnology (NASDAQ:NNNN) is one of the 13 Best German Stocks to Invest in Now. The company is engaged in the development of medical technology and the provision of in vitro diagnostics products. It was incorporated in 2021 and is based in Frankfurt. Anbio Biotechnology (NASDAQ:NNNN) had its initial public offering in February this year on […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Yahoo Finance
Jul 4, 2025

The IPO market in 2025 is being driven by a clear theme — bigger is better

The success of offerings like Circle, CoreWeave, and eToro Group — which all raised more than $600 million on their IPOs — is pushing leadership at private firms operating at that scale to move forward in the public offering process.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Apr 22, 2025

US Market's Undiscovered Gems and 2 Other Promising Small Caps

As the Dow Jones Industrial Average surges by more than 1,000 points, recovering from recent declines, and key indices like the S&P 500 and Nasdaq Composite also show significant gains, the U.S. market is experiencing a wave of optimism driven by earnings reports and tariff developments. In this dynamic environment, small-cap stocks present intriguing opportunities for investors seeking to capitalize on potential growth; identifying undiscovered gems within these smaller companies can be an...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.